Cargando…

Liver parameters as part of a non-invasive model for prediction of all-cause mortality after myocardial infarction

INTRODUCTION: Liver parameters are associated with cardiovascular disease risk and severity of stenosis. It is unclear whether liver parameters could predict the long-term outcome of patients after acute myocardial infarction (AMI). We performed an unbiased analysis of the predictive value of serum...

Descripción completa

Detalles Bibliográficos
Autores principales: Baars, Theodor, Sowa, Jan-Peter, Neumann, Ursula, Hendricks, Stefanie, Jinawy, Mona, Kälsch, Julia, Gerken, Guido, Rassaf, Tienush, Heider, Dominik, Canbay, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963137/
https://www.ncbi.nlm.nih.gov/pubmed/32051708
http://dx.doi.org/10.5114/aoms.2018.75678
_version_ 1783488216948539392
author Baars, Theodor
Sowa, Jan-Peter
Neumann, Ursula
Hendricks, Stefanie
Jinawy, Mona
Kälsch, Julia
Gerken, Guido
Rassaf, Tienush
Heider, Dominik
Canbay, Ali
author_facet Baars, Theodor
Sowa, Jan-Peter
Neumann, Ursula
Hendricks, Stefanie
Jinawy, Mona
Kälsch, Julia
Gerken, Guido
Rassaf, Tienush
Heider, Dominik
Canbay, Ali
author_sort Baars, Theodor
collection PubMed
description INTRODUCTION: Liver parameters are associated with cardiovascular disease risk and severity of stenosis. It is unclear whether liver parameters could predict the long-term outcome of patients after acute myocardial infarction (AMI). We performed an unbiased analysis of the predictive value of serum parameters for long-term prognosis after AMI. MATERIAL AND METHODS: In a retrospective, observational, single-center, cohort study, 569 patients after AMI were enrolled and followed up until 6 years for major adverse cardiovascular events, including cardiac death. Patients were classified into non-survivors (n = 156) and survivors (n = 413). Demographic and laboratory data were analyzed using ensemble feature selection (EFS) and logistic regression. Correlations were performed for serum parameters. RESULTS: Age (73; 64; p < 0.01), alanine aminotransferase (ALT; 93 U/l; 40 U/l; p < 0.01), aspartate aminotransferase (AST; 162 U/l; 66 U/l; p < 0.01), C-reactive protein (CRP; 4.7 U/l; 1.6 U/l; p < 0.01), creatinine (1.6; 1.3; p < 0.01), γ-glutamyltransferase (GGT; 71 U/l; 46 U/l; p < 0.01), urea (29.5; 20.5; p < 0.01), estimated glomerular filtration rate (eGFR; 49.6; 61.4; p < 0.01), troponin (13.3; 7.6; p < 0.01), myoglobin (639; 302; p < 0.01), and cardiovascular risk factors (hypercholesterolemia p < 0.02, family history p < 0.01, and smoking p < 0.01) differed significantly between non-survivors and survivors. Age, AST, CRP, eGFR, myoglobin, sodium, urea, creatinine, and troponin correlated significantly with death (r = –0.29; 0.14; 0.31; –0.27; 0.20; –0.13; 0.33; 0.24; 0.12). A prediction model was built including age, CRP, eGFR, myoglobin, and urea, achieving an AUROC of 77.6% to predict long-term survival after AMI. CONCLUSIONS: Non-invasive parameters, including liver and renal markers, can predict long-term outcome of patients after AMI.
format Online
Article
Text
id pubmed-6963137
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-69631372020-02-12 Liver parameters as part of a non-invasive model for prediction of all-cause mortality after myocardial infarction Baars, Theodor Sowa, Jan-Peter Neumann, Ursula Hendricks, Stefanie Jinawy, Mona Kälsch, Julia Gerken, Guido Rassaf, Tienush Heider, Dominik Canbay, Ali Arch Med Sci Clinical Research INTRODUCTION: Liver parameters are associated with cardiovascular disease risk and severity of stenosis. It is unclear whether liver parameters could predict the long-term outcome of patients after acute myocardial infarction (AMI). We performed an unbiased analysis of the predictive value of serum parameters for long-term prognosis after AMI. MATERIAL AND METHODS: In a retrospective, observational, single-center, cohort study, 569 patients after AMI were enrolled and followed up until 6 years for major adverse cardiovascular events, including cardiac death. Patients were classified into non-survivors (n = 156) and survivors (n = 413). Demographic and laboratory data were analyzed using ensemble feature selection (EFS) and logistic regression. Correlations were performed for serum parameters. RESULTS: Age (73; 64; p < 0.01), alanine aminotransferase (ALT; 93 U/l; 40 U/l; p < 0.01), aspartate aminotransferase (AST; 162 U/l; 66 U/l; p < 0.01), C-reactive protein (CRP; 4.7 U/l; 1.6 U/l; p < 0.01), creatinine (1.6; 1.3; p < 0.01), γ-glutamyltransferase (GGT; 71 U/l; 46 U/l; p < 0.01), urea (29.5; 20.5; p < 0.01), estimated glomerular filtration rate (eGFR; 49.6; 61.4; p < 0.01), troponin (13.3; 7.6; p < 0.01), myoglobin (639; 302; p < 0.01), and cardiovascular risk factors (hypercholesterolemia p < 0.02, family history p < 0.01, and smoking p < 0.01) differed significantly between non-survivors and survivors. Age, AST, CRP, eGFR, myoglobin, sodium, urea, creatinine, and troponin correlated significantly with death (r = –0.29; 0.14; 0.31; –0.27; 0.20; –0.13; 0.33; 0.24; 0.12). A prediction model was built including age, CRP, eGFR, myoglobin, and urea, achieving an AUROC of 77.6% to predict long-term survival after AMI. CONCLUSIONS: Non-invasive parameters, including liver and renal markers, can predict long-term outcome of patients after AMI. Termedia Publishing House 2018-05-15 /pmc/articles/PMC6963137/ /pubmed/32051708 http://dx.doi.org/10.5114/aoms.2018.75678 Text en Copyright: © 2018 Termedia & Banach http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Clinical Research
Baars, Theodor
Sowa, Jan-Peter
Neumann, Ursula
Hendricks, Stefanie
Jinawy, Mona
Kälsch, Julia
Gerken, Guido
Rassaf, Tienush
Heider, Dominik
Canbay, Ali
Liver parameters as part of a non-invasive model for prediction of all-cause mortality after myocardial infarction
title Liver parameters as part of a non-invasive model for prediction of all-cause mortality after myocardial infarction
title_full Liver parameters as part of a non-invasive model for prediction of all-cause mortality after myocardial infarction
title_fullStr Liver parameters as part of a non-invasive model for prediction of all-cause mortality after myocardial infarction
title_full_unstemmed Liver parameters as part of a non-invasive model for prediction of all-cause mortality after myocardial infarction
title_short Liver parameters as part of a non-invasive model for prediction of all-cause mortality after myocardial infarction
title_sort liver parameters as part of a non-invasive model for prediction of all-cause mortality after myocardial infarction
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963137/
https://www.ncbi.nlm.nih.gov/pubmed/32051708
http://dx.doi.org/10.5114/aoms.2018.75678
work_keys_str_mv AT baarstheodor liverparametersaspartofanoninvasivemodelforpredictionofallcausemortalityaftermyocardialinfarction
AT sowajanpeter liverparametersaspartofanoninvasivemodelforpredictionofallcausemortalityaftermyocardialinfarction
AT neumannursula liverparametersaspartofanoninvasivemodelforpredictionofallcausemortalityaftermyocardialinfarction
AT hendricksstefanie liverparametersaspartofanoninvasivemodelforpredictionofallcausemortalityaftermyocardialinfarction
AT jinawymona liverparametersaspartofanoninvasivemodelforpredictionofallcausemortalityaftermyocardialinfarction
AT kalschjulia liverparametersaspartofanoninvasivemodelforpredictionofallcausemortalityaftermyocardialinfarction
AT gerkenguido liverparametersaspartofanoninvasivemodelforpredictionofallcausemortalityaftermyocardialinfarction
AT rassaftienush liverparametersaspartofanoninvasivemodelforpredictionofallcausemortalityaftermyocardialinfarction
AT heiderdominik liverparametersaspartofanoninvasivemodelforpredictionofallcausemortalityaftermyocardialinfarction
AT canbayali liverparametersaspartofanoninvasivemodelforpredictionofallcausemortalityaftermyocardialinfarction